non branded semaglutide Eli Lilly's Orforglipron: A Promising Obesity Treatment Option | Aasish Jampala posted on the topic Novo Nordisk medicines containing semaglutide

bloating is a recognised common side effect of the medication caused by delayed gastric emptying

The women drawn to this approach tend to fall into three overlapping groups: those who've finished a weight-loss phase and would like to keep the result without staying on a full dose forever, those whose bodies respond so strongly that the standard schedule always felt like driving with the pedal floored, and those who never wanted dramatic weight loss in the first place, just relief from the food noise and appetite chaos that showed up somewhere in perimenopause and refused to leave

Results In Studies 2, 3, and 4, 16% of WEGOVY injection-treated patients and 19% of the placebo-treated patients discontinued therapy

Additionally, weight changes may revert once you stop microdosing, as seen with standard semaglutide doses

Such changes may indicate that the medication has degraded or become contaminated